French adopt tax increase on medtech sales, as financing bill clears lower house
This article was originally published in Clinica
The tax that medtech companies must pay for products sold in France will rise from 0.25% of their revenue generated in the country to 0.29% as of next year.
You may also be interested in...
In responding to industry’s plea for more time to comply with the EU’s MDR, the European Commission’s proposed one-year delay may also create some unwelcome repercussions for manufacturers and notified bodies.
With hospitals throughout the EU short of urgently needed COVID-19 medical supplies, including respiratory equipment, there are ways for companies to sell and deliver their products quickly.
With many non-CE marked products being allowed onto various EU member state markets, who is going to monitor compliance? TÜV-SÜD’s Bassil Akra calls for cooperation to avoid unsafe products being used on patients.